Validation of a Telemetry System for Measurement of Blood Pressure, Electrocardiogram and Locomotor Activity in Beagle Dogs

1997 ◽  
Vol 19 (7) ◽  
pp. 1135-1160 ◽  
Author(s):  
A. R.M. Gelzer ◽  
H. A. Ball
2010 ◽  
Vol 1 (1) ◽  
pp. 75-85 ◽  
Author(s):  
Claudio Signer ◽  
Thomas Ruf ◽  
Franz Schober ◽  
Gerhard Fluch ◽  
Thomas Paumann ◽  
...  

1999 ◽  
Vol 277 (4) ◽  
pp. H1540-H1545 ◽  
Author(s):  
Heinz Rupp ◽  
Bernhard Maisch

We addressed the hypothesis that hypercaloric diets induce hyperkinetic hypertension irrespective of day-night cycle and locomotor activity that is associated with altered cardiac myosin isozymes. Normotensive rats with implanted radiotelemetry pressure transducers were fed increasing amounts of coconut fat (8, 16, and 24%, each for 2 wk) corresponding to 20–47% of total calories from fat. Thereafter, increasing amounts of sucrose (16, 32, and 50%) and fructose (50%) were added to the 24% fat diet corresponding to 13–40% of total calories from sugar. In contrast to the fat diets, the 32% and 50% sucrose diets as well as the 50% fructose diets increased ( P < 0.05) blood pressure (systolic maximum +13 mmHg, diastolic maximum +4 mmHg, mean maximum +7 mmHg) and heart rate (maximum +50 beats/min) irrespective of the day-night cycle and the unaltered locomotor activity. Furthermore, body weight increased ( P < 0.05) during the 32% and 50% sucrose feedings. The increased blood pressure and heart rate normalized after rats were fed a regular chow. We concluded that an excessive caloric intake results in hyperkinetic hypertension that increases the myosin V1proportion.


1995 ◽  
Vol 59 (8) ◽  
pp. 565-573 ◽  
Author(s):  
Hiroaki Sano ◽  
Hiroshi Hayashi ◽  
Mitsutaka Makino ◽  
Hiroto Takezawa ◽  
Makoto Hirai ◽  
...  

2017 ◽  
Vol 85 ◽  
pp. 29-37 ◽  
Author(s):  
Anfisa Popova ◽  
Darya Tsvirkun ◽  
Oleg Dolgov ◽  
Konstantin Anokhin ◽  
Jeffrey Alberts ◽  
...  

2014 ◽  
Vol 87 ◽  
pp. 344-347 ◽  
Author(s):  
M. Caldara ◽  
B. Nodari ◽  
V. Re ◽  
B. Bonandrini

Micromachines ◽  
2021 ◽  
Vol 12 (8) ◽  
pp. 992
Author(s):  
Takahiro Ito ◽  
Takashi Ota ◽  
Rei Kono ◽  
Yoshitaka Miyaoka ◽  
Hidetoshi Ishibashi ◽  
...  

Hemofiltration removes water and small molecules from the blood via nanoporous filtering membranes. This paper discusses a pump-free hemofiltration device driven by the pressure difference between the artery and the vein. In the design of the filtering device, oncotic pressure needs to be taken into consideration. Transmembrane pressure (TMP) determines the amount and direction of hemofiltration, which is calculated by subtracting the oncotic pressure from the blood pressure. Blood pressure decreases as the channels progress from the inlet to the outlet, while oncotic pressure increases slightly since no protein is removed from the blood to the filtrate in hemofiltration. When TMP is negative, the filtrate returns to the blood, i.e., backfiltration takes place. A small region of the device with negative TMP would thus result in a small amount of or even zero filtrates. First, we investigated this phenomenon using in vitro experiments. We then designed a hemofiltration system taking backfiltration into consideration. We divided the device into two parts. In the first part, the device has channels for the blood and filtrate with a nanoporous membrane. In the second part, the device does not have channels for filtration. This design ensures TMP is always positive in the first part and prevents backfiltration. The concept was verified using in vitro experiments and ex vivo experiments in beagle dogs. Given the simplicity of the device without pumps or electrical components, the proposed pump-free hemofiltration device may prove useful for either implantable or wearable hemofiltration.


Sign in / Sign up

Export Citation Format

Share Document